Moody National Bank Trust Division’s West Pharmaceutical WST Stock Holding History

Moody National Bank Trust Division’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-741	Closed	-$278K	–	647
2023 Q3	$278K	Buy	741 +9	+1%	+$3.48K	0.02%	520
2023 Q2	$280K	Hold	732	–	–	0.02%	527
2023 Q1	$254K	Buy	+732	New	+$214K	0.02%	544
2022 Q3	–	Sell	-692	Closed	-$209K	–	595
2022 Q2	$209K	Buy	+692	New	+$225K	0.02%	489

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Moody National Bank Trust Division's WST Position: Q4 2023 in Review

Moody National Bank Trust Division sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 741 shares — an estimated $278K sold.

Moody National Bank Trust Division first reported a position in WST in Q2 2022 and held it in 4 quarters. The position peaked at $280K in Q2 2023. 782 funds tracked by Wall St. Rank hold WST as of Q4 2023.

Moody National Bank Trust Division reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
Moody National Bank Trust Division sold 741 West Pharmaceutical shares in Q4 2023, an estimated $278K.
Moody National Bank Trust Division first reported a position in West Pharmaceutical in Q2 2022 and held it in 4 quarters.
Moody National Bank Trust Division's West Pharmaceutical position peaked at $280K in Q2 2023.
782 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Moody National Bank Trust Division's 13F filing for Q4 2023, filed 11 Jan 2024.